Skip to content
Conference

Adaptation Depth Over Synthetic Augmentation for Classification of Imbalanced Circulating Tumor Cells

Aug 2026 · International Conference on Advanced Mechatronic Systems · pp. 19-24 · 0 citations · 27 references

Abstract

Circulating tumor cells (CTCs) are a non-invasive biomarker of metastasis. However, they are extremely rare, making automated detection in fluorescence microscopy images a severely class-imbalanced learning problem with a small, fixed-size positive class. A common approach is to synthesize additional minority examples with a generative model. On the hardest subset of a CTC dataset (positive class = abnormal CTCs, 106 patches vs. a negative class restricted to the single most CTC-like “suspicious” subtype; imbalance $\approx 5: 1)$, we investigate whether diffusion-based synthetic augmentation is effective. Each configuration is evaluated over 10 data splits (5-fold ×2 repeats). Across synthetic dose, generation guidance, and a transfer-based generator, synthetic augmentation does not significantly outperform simple class balancing on the threshold-independent primary metric: the area under the precision-recall curve (PR-AUC). PR-AUC is instead governed by how deeply the ImageNet-pretrained backbone is adapted: across splits, it rises monotonically with unfreeze depth, from 0.887 (frozen) to 0.965 (full). The frozen head performs significantly worse, making adaptation depth the only intervention with a statistically robust across-split lift. The same frozen-versus-adapted axis governs the generator: a pretrained diffusion model fine-tuned deeply enough passes a train-on-synthetic/test-on-real (TSTR) fidelity gate, yet still does not improve downstream classification, so passing TSTR does not imply a downstream gain. Imbalance losses and threshold tuning shift the operating point without changing the curve. On this task and modality, performance is bound by representation capacity.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.